464 related articles for article (PubMed ID: 33962838)
1. The impact of disruptions caused by the COVID-19 pandemic on global polio eradication.
Kalkowska DA; Voorman A; Pallansch MA; Wassilak SGF; Cochi SL; Badizadegan K; Thompson KM
Vaccine; 2023 Apr; 41 Suppl 1():A12-A18. PubMed ID: 33962838
[TBL] [Abstract][Full Text] [Related]
2. Updated Characterization of Poliovirus Transmission in Pakistan and Afghanistan and the Impacts of Different Outbreak Response Vaccine Options.
Kalkowska DA; Pallansch MA; Cochi SL; Thompson KM
J Infect Dis; 2021 Nov; 224(9):1529-1538. PubMed ID: 33885734
[TBL] [Abstract][Full Text] [Related]
3. Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response.
Kalkowska DA; Pallansch MA; Wassilak SGF; Cochi SL; Thompson KM
Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A136-A141. PubMed ID: 33994237
[TBL] [Abstract][Full Text] [Related]
4. The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities.
Burkholder B; Wadood Z; Kassem AM; Ehrhardt D; Zomahoun D
Vaccine; 2023 Apr; 41 Suppl 1():A2-A11. PubMed ID: 34756614
[TBL] [Abstract][Full Text] [Related]
5. Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPV.
Kalkowska DA; Thompson KM
Risk Anal; 2021 Feb; 41(2):312-319. PubMed ID: 32936466
[TBL] [Abstract][Full Text] [Related]
6. Progress Toward Polio Eradication - Worldwide, January 2018-March 2020.
Chard AN; Datta SD; Tallis G; Burns CC; Wassilak SGF; Vertefeuille JF; Zaffran M
MMWR Morb Mortal Wkly Rep; 2020 Jun; 69(25):784-789. PubMed ID: 32584798
[TBL] [Abstract][Full Text] [Related]
7. Progress Toward Polio Eradication - Worldwide, January 2019-June 2021.
Bigouette JP; Wilkinson AL; Tallis G; Burns CC; Wassilak SGF; Vertefeuille JF
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1129-1135. PubMed ID: 34437527
[TBL] [Abstract][Full Text] [Related]
8. Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.
Molodecky NA; Jafari H; Safdar RM; Ahmed JA; Mahamud A; Bandyopadhyay AS; Shukla H; Quddus A; Zaffran M; Sutter RW; Grassly NC; Blake IM
Vaccine; 2023 Apr; 41 Suppl 1():A93-A104. PubMed ID: 34629206
[TBL] [Abstract][Full Text] [Related]
9. Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2020-June 2021.
Alleman MM; Jorba J; Henderson E; Diop OM; Shaukat S; Traoré MA; Wiesen E; Wassilak SGF; Burns CC
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1691-1699. PubMed ID: 34882653
[TBL] [Abstract][Full Text] [Related]
10. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
Duintjer Tebbens RJ; Hampton LM; Thompson KM
BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
[TBL] [Abstract][Full Text] [Related]
11. An Updated Economic Analysis of the Global Polio Eradication Initiative.
Thompson KM; Kalkowska DA
Risk Anal; 2021 Feb; 41(2):393-406. PubMed ID: 33590521
[TBL] [Abstract][Full Text] [Related]
12. Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain.
Kalkowska DA; Pallansch MA; Wilkinson A; Bandyopadhyay AS; Konopka-Anstadt JL; Burns CC; Oberste MS; Wassilak SGF; Badizadegan K; Thompson KM
Risk Anal; 2021 Feb; 41(2):329-348. PubMed ID: 33174263
[TBL] [Abstract][Full Text] [Related]
13. Emerging challenges to realizing global polio eradication and their solutions.
M A S
East Mediterr Health J; 2022 Jul; 28(7):515-520. PubMed ID: 35959667
[TBL] [Abstract][Full Text] [Related]
14. Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020.
Darwar R; Biya O; Greene SA; Jorba J; Al Safadi M; Franka R; Wiesen E; Durry E; Pallansch MA
Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A25-A34. PubMed ID: 36863925
[TBL] [Abstract][Full Text] [Related]
15. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
Famulare M; Selinger C; McCarthy KA; Eckhoff PA; Chabot-Couture G
PLoS Biol; 2018 Apr; 16(4):e2002468. PubMed ID: 29702638
[TBL] [Abstract][Full Text] [Related]
16. Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, July 2019-February 2020.
Alleman MM; Jorba J; Greene SA; Diop OM; Iber J; Tallis G; Goel A; Wiesen E; Wassilak SGF; Burns CC
MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(16):489-495. PubMed ID: 32324719
[TBL] [Abstract][Full Text] [Related]
17. Insights From Modeling Preventive Supplemental Immunization Activities as a Strategy to Eliminate Wild Poliovirus Transmission in Pakistan and Afghanistan.
Kalkowska DA; Thompson KM
Risk Anal; 2021 Feb; 41(2):266-272. PubMed ID: 32144841
[TBL] [Abstract][Full Text] [Related]
18. Progress Toward Poliomyelitis Eradication - Afghanistan, January 2020-November 2021.
Sadigh KS; Akbar IE; Wadood MZ; Shukla H; Jorba J; Chaudhury S; Martinez M
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(3):85-89. PubMed ID: 35051135
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa.
Cooper LV; Bandyopadhyay AS; Gumede N; Mach O; Mkanda P; Ndoutabé M; Okiror SO; Ramirez-Gonzalez A; Touray K; Wanyoike S; Grassly NC; Blake IM
Lancet Infect Dis; 2022 Feb; 22(2):284-294. PubMed ID: 34648733
[TBL] [Abstract][Full Text] [Related]
20. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
Orenstein WA;
Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
